Young Eun Kim Selected Research

Hyperoxia

3/2024	Mesenchymal Stem Cells Reduce the Extracellular Mitochondrial DNA-Mediated TLR9 Activation in Neonatal Hyperoxia-Induced Lung Injury.
9/2022	Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice.
1/2019	Antenatal betamethasone enhanced the detrimental effects of postnatal dexamethasone on hyperoxic lung and brain injuries in newborn rats.
1/2019	WKYMVm hexapeptide, a strong formyl peptide receptor 2 agonist, attenuates hyperoxia-induced lung injuries in newborn mice.
1/2018	Intratracheal transplantation of mesenchymal stem cells attenuates hyperoxia-induced lung injury by down-regulating, but not direct inhibiting formyl peptide receptor 1 in the newborn mice.
1/2018	Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury.
1/2016	Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Eun Kim Research Topics

Disease

24	Parkinson Disease (Parkinson's Disease) 02/2024 - 12/2011
9	Inflammation (Inflammations) 03/2024 - 01/2018
7	Hyperoxia 03/2024 - 01/2016
7	Parkinsonian Disorders (Parkinsonism) 07/2017 - 08/2012
6	Lung Injury 03/2024 - 01/2016
6	Brain Injuries (Brain Injury) 04/2022 - 01/2016
6	Neoplasms (Cancer) 03/2021 - 08/2010
5	Gliosis 04/2022 - 11/2018
4	Pneumonia (Pneumonitis) 03/2024 - 01/2018
4	Dystonia (Limb Dystonia) 01/2017 - 01/2015
3	Dyskinesias (Dyskinesia) 05/2018 - 09/2013
2	Thrombosis (Thrombus) 09/2022 - 07/2021
2	Hemorrhage 04/2022 - 01/2021
2	Synucleinopathies 01/2022 - 01/2022
2	Brain Infarction 10/2021 - 05/2019
2	REM Sleep Behavior Disorder 11/2020 - 02/2015
2	Bacteremia 03/2020 - 11/2018
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 10/2019 - 05/2019
2	Onchocerciasis 01/2018 - 01/2017
2	Cerebellar Ataxia (Dysmetria) 07/2017 - 01/2015
2	Neuroinflammatory Diseases 01/2017 - 07/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 11/2002
2	Movement Disorders (Movement Disorder) 01/2016 - 02/2015
2	Ocular Onchocerciasis (River Blindness) 05/2015 - 04/2015
2	Dementia (Dementias) 06/2014 - 06/2013
2	Tremor (Tremors) 01/2014 - 09/2013
2	Carcinoma (Carcinomatosis) 01/2011 - 05/2009
1	Acute Lung Injury 05/2023
1	Huntington Disease (Huntington's Disease) 01/2023
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Infections 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021
1	Embolism and Thrombosis 07/2021
1	Thrombophlebitis 07/2021
1	Disseminated Intravascular Coagulation 07/2021
1	Pulmonary Embolism 07/2021
1	Thrombocytopenia (Thrombopenia) 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 03/2021
1	COVID-19 03/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021
1	Measles 01/2021
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Takotsubo Cardiomyopathy 05/2020
1	Vomiting 05/2020
1	Heart Failure 05/2020
1	Nausea 05/2020
1	Cough 05/2020
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 02/2020

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2011
6	Levodopa (L Dopa)FDA LinkGeneric 07/2017 - 08/2012
5	CytokinesIBA 04/2022 - 01/2016
4	Thrombin FDA Link 04/2022 - 07/2008
4	Amantadine (Aman)FDA LinkGeneric 05/2018 - 12/2011
3	alpha-SynucleinIBA 02/2024 - 01/2021
3	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 09/2022 - 01/2018
3	SynucleinsIBA 01/2022 - 11/2020
3	Ivermectin (Mectizan)FDA Link 01/2018 - 04/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021 - 01/2021
2	VaccinesIBA 03/2021 - 10/2014
2	Myelin Basic ProteinIBA 01/2021 - 01/2016
2	Capsules (Microcapsules)IBA 03/2020 - 01/2011
2	Neuroprotective AgentsIBA 05/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2019 - 01/2016
2	EnzymesIBA 01/2018 - 11/2002
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 06/2017 - 03/2015
2	Propofol (Diprivan)FDA LinkGeneric 01/2016 - 09/2014
2	HDL CholesterolIBA 01/2016 - 03/2015
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2016 - 12/2014
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 03/2015
2	Fentanyl (Sublimaze)FDA LinkGeneric 01/2016 - 09/2014
2	CholesterolIBA 03/2015 - 08/2010
1	Mitochondrial DNA (mtDNA)IBA 03/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	Suppressor of Cytokine Signaling 3 ProteinIBA 05/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Thromboxane B2IBA 09/2022
1	PTEN-induced putative kinaseIBA 01/2022
1	InterleukinsIBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	NucleotidesIBA 01/2022
1	InflammasomesIBA 01/2022
1	ChAdOx1 nCoV-19IBA 07/2021
1	Dacarbazine (DIC)FDA LinkGeneric 07/2021
1	Azathioprine (Imuran)FDA LinkGeneric 03/2021
1	IsotopesIBA 02/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	Amino Acids FDA Link 02/2021
1	ORALIT (ORS)IBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2020

Therapy/Procedure

10	Therapeutics 03/2024 - 01/2012
8	Deep Brain Stimulation 06/2020 - 07/2013
7	Transplantation 03/2024 - 01/2016
3	Endovascular Aneurysm Repair 04/2019 - 12/2016
3	Electrodes (Electrode) 01/2017 - 04/2013
2	Intraventricular Injections 03/2020 - 11/2018
1	Denervation 11/2020
1	Extracorporeal Membrane Oxygenation 05/2020